Search - tctmd.com

Displaying 41 - 60 of 77

Sort: Relevancy | Date

News Daily News

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

Caitlin E. Cox

September 18, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Daily News

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

Michael O'Riordan

March 13, 2020

News Daily News

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

Yael L. Maxwell

December 12, 2019

News Conference News AHA 2019

LDL Levels Still Too High in Many Statin-Treated Patients: PINNACLE

Michael O'Riordan

November 13, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Todd Neale

July 24, 2019

News Daily News

Microvascular Disease Quadruples Risk of Leg Amputation

L.A. McKeown

July 08, 2019

News Daily News

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

Marcus A. Banks

June 24, 2019

News Daily News

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

Caitlin E. Cox

June 12, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Daily News

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

L.A. McKeown

January 03, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Conference News EAS 2018

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

Yael L. Maxwell

May 14, 2018

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

News Daily News

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Caitlin E. Cox

December 05, 2017

News Conference News AHA 2017

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Michael O'Riordan

November 17, 2017

Advertisement

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Ideal CV Health Over the Long Term Linked With Better Survival, Less Disease

‘Stronger’ Evidence That High Lp(a) Concentrations Cause CVD

LDL Levels Still Too High in Many Statin-Treated Patients: PINNACLE

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Smoking More Strongly Linked to Long-term Risks of PAD Than to Other Types of CVD

Microvascular Disease Quadruples Risk of Leg Amputation

Genetic Data Hint at Causal Link Between High BMI and Cardiovascular Diseases

CAD’s Genetic Basis Strongly Overlaps With Other Vascular Conditions and Risk Factors

One in Two Americans Have Cardiovascular Disease: AHA Stats

AHA Scientific Statement: Get PAD Patients Moving to Improve Symptoms and QoL

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

ORION 1 Data Show Lipoprotein-Lowering Beyond LDL Cholesterol With Injectable Inclisiran

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Diabetes Drugs Show Benefit in PAD, but Only Mixed Results in Primary Prevention of CV Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content